Position in ONC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,984,775
+$1,852,726 QoQ
Shares Held
10,474
+174.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#88
of 282 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. ONC ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
578,634 | $287,424,866 | |
| 2 | ARGX |
Argenx SE
|
301,000 | $279,258,770 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,048,014 | $196,272,061 | |
| 4 | ORKA |
Oruka Therapeutics, Inc.
|
1,657,190 | $157,714,772 | |
| 5 | INSM |
INSMED Inc
|
1,393,418 | $148,566,226 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,449,547 | $134,725,085 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,731,909 | $123,665,167 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
6,185,970 | $115,739,498 |
All Filings in ONC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,984,775 | 10,474 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,132,049 | 3,812 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $574,200 | 1,890 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,514,637 | 33,797 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,367,624 | 38,698 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,615,493 | 35,329 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,322,438 | 34,229 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $13,185,247 | 58,729 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,656,489 | 25,629 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,898,646 | 24,929 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,158,296 | 28,600 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $9,569,084 | 53,200 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,818,660 | 10,200 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,551,389 | 58,235 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,587,930 | 34,500 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $943,740 | 7,000 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $6,231,390 | 23,000 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $8,349,000 | 23,000 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $28,930,917 | 84,300 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $20,780,376 | 59,700 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $27,673,569 | 107,100 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $11,285,736 | 39,400 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $10,927,200 | 58,000 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,201,935 | 58,500 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||